The cuts included about 20 people in the FDA’s office of neurological and physical medicine devices, several of whom worked on Neuralink, according to the two sources, who asked not to be ...
Jim Jones, the head of the Food and Drug Administration’s (FDA) food division, resigned Monday, citing the mass firings of agency staff. According to a copy of his resignation letter viewed by ...
Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in his confirmation hearing on Thursday, aligning himself with the Make ...
The FDA is also working on a symbol that can be put on packages to help consumers more easily identify foods that are considered healthy, and it’s developing a plan for nutrition labeling that ...
FDA BANS ARTIFICIAL RED DYE: WHAT THIS MEANS FOR CONSUMERS The head of the FDA's food division, Jim Jones, resigned on Monday following layoffs within the division that he argues were ...
FDA slaps China-based API makers with separate warning letters outlining quality, testing shortfalls
A pair of Chinese manufacturers with active pharmaceutical ingredients that were previously shipped to the U.S. have landed in the FDA’s crosshairs thanks to quality shortfalls, poor testing ...
A Form 483 is a type of agency report containing "observations" that FDA inspectors "deem to be objectionable." Dexcom manufactures its products at its headquarters in San Diego, California and at ...
Dr. Marty Makary — a surgeon, author and researcher — lauded the FDA’s “gold-standard science” in testimony before the Senate’s health committee, which will vote on whether to advance ...
WASHINGTON — The layoffs over the weekend at the Food and Drug Administration appear to have hit the AI and digital health staff particularly hard at a time when federal regulators are ...
DOGE reportedly fired the FDA employees who were reviewing clinical trials for Elon Musk’s Neuralink
Elon Musk's Neuralink has FDA approval for its clinical trials. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our ...
Due to concerns about these chemicals’ links to cancer risks, the FDA under the Biden administration considered proposing a ban on these ingredients in certain cosmetic products such as chemical ...
A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. Fellow Japanese drugmaker Ono Pharmaceutical has won an FDA green light for vimseltinib to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback